CDH Investments-backed Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd plans to raise as much as 1.07 billion yuan ($151 million) in an initial public offering (IPO) on the Nasdaq-style STAR Market of the Shanghai Stock Exchange.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
